Medtronic has announced that it has completed the acquisition of Twelve, a privately-held medical device company based in Redwood City, CA, focused on the development of a transcatheter mitral valve replacement (TMVR) device.

"This acquisition supports Medtronic's therapy innovation strategy, as TMVR represents an important growth opportunity for our business. We look forward to welcoming the Twelve team to Medtronic to help deliver an exciting and differentiated therapy to patients," said Mr Sean Salmon, senior vice president and president, coronary and structural heart, Medtronic.

The Medtronic TMVR technology is not available for sale in any country.